Veraxa Biotech Statistics

NASDAQ: VRXAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.20+0.12 (+11.11%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Veraxa Biotech by the numbers

Veraxa Biotech has a market capitalization of $169.7 million based on 141.41M shares outstanding. With trailing EPS of $-0.57, Veraxa Biotech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.6% below its 50-day average and 84.7% below its 200-day average.

Average daily trading volume is 292.05K shares, or about $350,465 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VRXA valuation vs. peer median

VRXA compared with the median of 8 peer companies
Metric	VRXA	Peer median	Difference
Market cap	$169.69M	$156.43M	+8%
Avg. volume	292.05K	167.42K	+74%

Peer median across 8 companies: KRRO, NERV, ALXO, MENS, NBP, SDEV, MSLE, EMIS.

Valuation

Market cap: $169.69M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-0.57
Shares outstanding: 141.41M

Price and trading

Previous close: 1.08
Open: 1.16
Day range: 1.10 – 1.32
52-week range: 1.04 – 27.36
52-week change: -88.53%
50-day moving average: 1.61
200-day moving average: 7.82
Beta: —
Volume: 747.18K
Average volume: 292.05K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: —

Additional statistics

Market Cap: 169.69M
Eps: -0.57
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 27.36
Week52 Low: 1.04
Avg Volume: 292.05K
Shares Outstanding: 141.41M
Ma50: 1.61
Ma200: 7.82
Pct From52w High: -95.61%
Pct From52w Low: 15.38%